129 related articles for article (PubMed ID: 27063163)
1. [Expression of YY 1 protein in human insulinoma and its clinical implication].
Li WX; Huang YE; Shi XX; Lin PX; Zhou ZN; Zhang YZ; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):361-4. PubMed ID: 27063163
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.
Cao Y; Gao Z; Li L; Jiang X; Shan A; Cai J; Peng Y; Li Y; Jiang X; Huang X; Wang J; Wei Q; Qin G; Zhao J; Jin X; Liu L; Li Y; Wang W; Wang J; Ning G
Nat Commun; 2013; 4():2810. PubMed ID: 24326773
[TBL] [Abstract][Full Text] [Related]
3. Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.
Cromer MK; Choi M; Nelson-Williams C; Fonseca AL; Kunstman JW; Korah RM; Overton JD; Mane S; Kenney B; Malchoff CD; Stalberg P; Akerström G; Westin G; Hellman P; Carling T; Björklund P; Lifton RP
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4062-7. PubMed ID: 25787250
[TBL] [Abstract][Full Text] [Related]
4. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.
Lichtenauer UD; Di Dalmazi G; Slater EP; Wieland T; Kuebart A; Schmittfull A; Schwarzmayr T; Diener S; Wiese D; Thasler WE; Reincke M; Meitinger T; Schott M; Fassnacht M; Bartsch DK; Strom TM; Beuschlein F
J Clin Endocrinol Metab; 2015 May; 100(5):E776-82. PubMed ID: 25763608
[TBL] [Abstract][Full Text] [Related]
6. Significance of the pathogenic mutation T372R in the Yin Yang 1 protein interaction with DNA--thermodynamic studies.
Nieborak A; Górecki A
FEBS Lett; 2016 Mar; 590(6):838-47. PubMed ID: 26910132
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine cancer: Insulinomas-recurrent mutations identified in YY1.
Greenhill C
Nat Rev Endocrinol; 2014 Mar; 10(3):127. PubMed ID: 24366121
[No Abstract] [Full Text] [Related]
8. T372R Mutation Status in Yin Yang 1 Gene in Insulinoma Patients.
Irshad K; Jyotsna VP; Agarwal S; Chosdol K; Pal S; Deepak RK
Horm Metab Res; 2017 Jun; 49(6):452-456. PubMed ID: 28472826
[TBL] [Abstract][Full Text] [Related]
9. Frequency and consequence of the recurrent
Parekh VI; Modali SD; Welch J; Simonds WF; Weinstein LS; Kebebew E; Agarwal SK
Endocr Relat Cancer; 2018 May; 25(5):L31-L35. PubMed ID: 29467239
[No Abstract] [Full Text] [Related]
10. Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance.
Song YL; Xu J; Zhao DC; Zhang TP; Jin KZ; Zhu LM; Yu S; Chen YJ
Endocr Pract; 2021 Sep; 27(9):874-880. PubMed ID: 33705973
[TBL] [Abstract][Full Text] [Related]
11. Mutation Status in Yin Yang 1 Gene in X-ray-Induced Insulinoma Cell Line Rin-5F.
Kiba T
Pancreas; 2020 Jul; 49(6):e49-e50. PubMed ID: 32590621
[No Abstract] [Full Text] [Related]
12. Yin Yang-1 increases apoptosis through Bax activation in pancreatic cancer cells.
Zhang JJ; Zhu Y; Yang C; Liu X; Peng YP; Jiang KR; Miao Y; Xu ZK
Oncotarget; 2016 May; 7(19):28498-509. PubMed ID: 27074573
[TBL] [Abstract][Full Text] [Related]
13. Expression of YY1 in Differentiated Thyroid Cancer.
Arribas J; Castellví J; Marcos R; Zafón C; Velázquez A
Endocr Pathol; 2015 May; 26(2):111-8. PubMed ID: 25698133
[TBL] [Abstract][Full Text] [Related]
14. A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4.
Rangel-Santiago JF; Baay-Guzman GJ; Duran-Padilla MA; Lopez-Bochm KA; Garcia-Romero BL; Hernandez-Cueto DD; Pantoja-Escobar G; Vega MI; Hernandez-Pando R; Huerta-Yepez S
Tuberculosis (Edinb); 2016 Jan; 96():87-95. PubMed ID: 26786659
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
16. Increased EpCAM expression in malignant insulinoma: potential clinical implications.
Raffel A; Eisenberger CF; Cupisti K; Schott M; Baldus SE; Hoffmann I; Aydin F; Knoefel WT; Stoecklein NH
Eur J Endocrinol; 2010 Feb; 162(2):391-8. PubMed ID: 20097833
[TBL] [Abstract][Full Text] [Related]
17. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
18. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
[TBL] [Abstract][Full Text] [Related]
20. Expression of transcription factor Yin Yang 1 in human osteosarcomas.
de Nigris F; Botti C; de Chiara A; Rossiello R; Apice G; Fazioli F; Fiorito C; Sica V; Napoli C
Eur J Cancer; 2006 Oct; 42(15):2420-4. PubMed ID: 16962318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
